2026-02914Notice

DEA Reviews New Importer for Controlled Meds

Published Date: 2/13/2026

Notice

Summary

S&B Pharma LLC, also known as Norac Pharma, wants to become an official importer of certain controlled drugs. This means they’ll be allowed to bring in specific medicines that need special handling. If anyone has concerns or wants a hearing, they must speak up by March 16, 2026, so don’t miss the deadline!

Analyzed Economic Effects

4 provisions identified: 2 benefits, 2 costs, 0 mixed.

Application to Import Two Schedule II Drugs

On January 13, 2026, S&B Pharma LLC DBA Norac Pharma applied to be registered to import ANPP (controlled substance code 8333, Schedule II) and Tapentadol (code 9780, Schedule II). The company plans to import intermediate forms of Tapentadol for further manufacturing and to import ANPP to bulk manufacture other controlled substances for distribution to its customers.

Finished Dosage Forms Not Authorized

The DEA notice states that authorization will not extend to the import of Food and Drug Administration-approved or non-approved finished dosage forms for commercial sale under this registration. The registration, if approved, is limited to the activities described in the application.

Deadline to Comment or Request Hearing

Registered bulk manufacturers of the affected drug classes and other applicants may submit comments or objections, or file a written request for a hearing, on or before March 16, 2026. Comments must be submitted electronically at https://www.regulations.gov and hearing requests must be sent to the DEA addresses listed in the notice.

Approval Conditional on Statutory Consistency

The notice states that approval of permit applications will occur only when the registrant's business activity is consistent with 21 U.S.C. 952(a)(2). That statutory consistency is a condition for authorization.

Your PRIA Score

Score Hidden

Personalized for You

How does this regulation affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Key Dates

Published Date
Comments Due
2/13/2026
3/16/2026

Department and Agencies

Department
Independent Agency
Agency
Justice Department
Drug Enforcement Administration
Source: View HTML
Back to Federal Register

Take It Personal

Get Your Personalized Policy View

Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.

Already have an account? Sign in